Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline in Acute Ischemic Stroke
NCT05154903Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Jul 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of citicoline in ischemic stroke (2 arms), sponsored by Ain Shams University. Primary endpoint: modified Rankin Scale at 3 months. Status: unknown.
02
Drugs
citicoline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05154903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05154903.